| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |